JGC
CHTP

J. Goldman & Co’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

J. Goldman & Co’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-500,000
Closed -$2.76M – 371
2014
Q1 		$2.76M Sell
500,000
-87,500
-15% -$439K 0.2% 141
2013
Q4 		$2.6M Buy
+587,500
New +$1.99M 0.33% 94

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

J. Goldman & Co's CHTP Position: Q2 2014 in Review

J. Goldman & Co sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 1,360,000 shares — an estimated $7.51M sold.

J. Goldman & Co first reported a position in CHTP in Q3 2013 and held it in 3 quarters. The position peaked at $7.51M in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • J. Goldman & Co reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • J. Goldman & Co sold 1,360,000 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $7.51M.
  • J. Goldman & Co first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q3 2013 and held it in 3 quarters.
  • J. Goldman & Co's CHELSEA THERAPEUTICS INT'L LTD position peaked at $7.51M in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on J. Goldman & Co's 13F filing for Q2 2014, filed 14 Aug 2014.